266
Participants
Start Date
June 20, 2018
Primary Completion Date
October 20, 2025
Study Completion Date
October 20, 2025
BI 907828
Film-coated tablet
Cliniques Universitaires Saint-Luc, Brussels
Rigshospitalet, København, København Ø
UZ Leuven, Leuven
Memorial Sloan-Kettering Cancer Center, New York
Helios Klinikum Berlin-Buch, Berlin
Hospital Clínico de Santiago, Santiago de Compostela
Fundación Jiménez Díaz, Madrid
Florida Cancer Specialists-Sarasota-61670, Sarasota
Universitätsmedizin Göttingen, Georg-August-Universität, Göttingen
SCRI Oncology Partners, Nashville
Norton Cancer Institute, Downtown, Louisville
START Midwest, Grand Rapids
Universitätsklinikum Köln (AöR), Cologne
University of Wisconsin, Madison
Universitätsklinikum Tübingen, Tübingen
The University of Texas MD Anderson Cancer Center, Houston
Sarcoma Oncology Center, Santa Monica
Sourasky Medical Center, Tel Aviv
Yale University School of Medicine, New Haven
The Ottawa Hospital, Ottawa
National Cancer Center Hospital, Tokyo, Chuo-ku
MED POLONIA SP Z O O, Clinical Trials Department,Poznan, Poznan
Oncology Center-Maria Sklodowska-Curie Institute, Warsaw
Severance Hospital, Seoul
Hospital Vall d'Hebron, Barcelona
Hospital Clínic de Barcelona, Barcelona
Karolinska Comprehensive Cancer Center, Stockholm
Lead Sponsor
Boehringer Ingelheim
INDUSTRY